Evidence map›Paper›PMID 35330731›Full record

ArticleFrontiers in genetics2022

A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.

Lianghua Luo, Leyan Li, Li Liu, Zongfeng Feng, Qingwen Zeng, Xufeng Shu, Yi Cao, Zhengrong Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 70 citations in OpenAlex.

  1. Observational
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Multifaceted Roles ofNon-coding RNA · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lianghua LuoDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Leyan LiQueen Mary School, Medical Department of Nanchang University, Nanchang, China.
Li LiuDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Zongfeng FengDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Qingwen ZengDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Xufeng ShuDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Yi CaoDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Zhengrong LiDepartment of Gastrointestinal Surgery, The First Affiliated Hospital, Nanchang University, Nanchang, China.
Nanchang University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

lncRNAmolecular characteristicsnecroptosisprognosissignaturestomach adenocarcinoma

Identifiers

PMID35330731
PMCPMC8940523
OpenAlexW4220734404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.